Table of Content

1 Herpes Simplex Virus (HSV) Vaccines Market Overview
1.1 Herpes Simplex Virus (HSV) Vaccines Product Scope
1.2 Herpes Simplex Virus (HSV) Vaccines Segment by Type
1.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 GEN-003
1.2.3 VCL-HB01
1.2.4 HSV529
1.2.5 Others
1.3 Herpes Simplex Virus (HSV) Vaccines Segment by Application
1.3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 HSV-1 (Oral Herpes)
1.3.3 HSV-2 (Genital Herpes)
1.4 Herpes Simplex Virus (HSV) Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Herpes Simplex Virus (HSV) Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Herpes Simplex Virus (HSV) Vaccines Price Trends (2016-2027)

2 Herpes Simplex Virus (HSV) Vaccines Estimates and Forecasts by Region
2.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Herpes Simplex Virus (HSV) Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Herpes Simplex Virus (HSV) Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2016-2027)
2.4.3 China Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2016-2027)
2.4.6 India Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2016-2027)
3 Global Herpes Simplex Virus (HSV) Vaccines Competition Landscape by Players
3.1 Global Top Herpes Simplex Virus (HSV) Vaccines Players by Sales (2016-2021)
3.2 Global Top Herpes Simplex Virus (HSV) Vaccines Players by Revenue (2016-2021)
3.3 Global Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Herpes Simplex Virus (HSV) Vaccines as of 2020)
3.4 Global Herpes Simplex Virus (HSV) Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Herpes Simplex Virus (HSV) Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Type
4.1 Global Herpes Simplex Virus (HSV) Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2016-2021)
4.2 Global Herpes Simplex Virus (HSV) Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by Type (2022-2027)
5 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Application
5.1 Global Herpes Simplex Virus (HSV) Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2016-2021)
5.2 Global Herpes Simplex Virus (HSV) Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by Application (2022-2027)

6 North America Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures
6.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Company
6.1.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Company (2016-2021)
6.1.2 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2016-2021)
6.2 North America Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type
6.2.1 North America Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application
6.3.1 North America Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application (2022-2027)

7 Europe Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures
7.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Company
7.1.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Company (2016-2021)
7.1.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2016-2021)
7.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type
7.2.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application
7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)

8 China Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures
8.1 China Herpes Simplex Virus (HSV) Vaccines Sales by Company
8.1.1 China Herpes Simplex Virus (HSV) Vaccines Sales by Company (2016-2021)
8.1.2 China Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2016-2021)
8.2 China Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type
8.2.1 China Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures
9.1 Japan Herpes Simplex Virus (HSV) Vaccines Sales by Company
9.1.1 Japan Herpes Simplex Virus (HSV) Vaccines Sales by Company (2016-2021)
9.1.2 Japan Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2016-2021)
9.2 Japan Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type
9.2.1 Japan Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures
10.1 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales by Company
10.1.1 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures
11.1 India Herpes Simplex Virus (HSV) Vaccines Sales by Company
11.1.1 India Herpes Simplex Virus (HSV) Vaccines Sales by Company (2016-2021)
11.1.2 India Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2016-2021)
11.2 India Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type
11.2.1 India Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application
11.3.1 India Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Herpes Simplex Virus (HSV) Vaccines Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Herpes Simplex Virus (HSV) Vaccines Business
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Herpes Simplex Virus (HSV) Vaccines Products Offered
12.1.5 Sanofi Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Business Overview
12.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Genocea Biosciences
12.3.1 Genocea Biosciences Corporation Information
12.3.2 Genocea Biosciences Business Overview
12.3.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Products Offered
12.3.5 Genocea Biosciences Recent Development
12.4 Vical
12.4.1 Vical Corporation Information
12.4.2 Vical Business Overview
12.4.3 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Vical Herpes Simplex Virus (HSV) Vaccines Products Offered
12.4.5 Vical Recent Development
...

13 Herpes Simplex Virus (HSV) Vaccines Manufacturing Cost Analysis
13.1 Herpes Simplex Virus (HSV) Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Herpes Simplex Virus (HSV) Vaccines
13.4 Herpes Simplex Virus (HSV) Vaccines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Herpes Simplex Virus (HSV) Vaccines Distributors List
14.3 Herpes Simplex Virus (HSV) Vaccines Customers

15 Market Dynamics
15.1 Herpes Simplex Virus (HSV) Vaccines Market Trends
15.2 Herpes Simplex Virus (HSV) Vaccines Drivers
15.3 Herpes Simplex Virus (HSV) Vaccines Market Challenges
15.4 Herpes Simplex Virus (HSV) Vaccines Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Herpes Simplex Virus (HSV) Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Herpes Simplex Virus (HSV) Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Herpes Simplex Virus (HSV) Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Region (2016-2021)
Table 5. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Region (2016-2021)
Table 8. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Company (2016-2021)
Table 14. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Company (2016-2021)
Table 16. Global Herpes Simplex Virus (HSV) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Simplex Virus (HSV) Vaccines as of 2020)
Table 17. Global Herpes Simplex Virus (HSV) Vaccines Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Herpes Simplex Virus (HSV) Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Herpes Simplex Virus (HSV) Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Type (2016-2021)
Table 22. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Type (2016-2021)
Table 23. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Type (2016-2021)
Table 25. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Type (2022-2027)
Table 26. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Type (2022-2027)
Table 28. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Type (2022-2027)
Table 29. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Application (2016-2021)
Table 30. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Application (2016-2021)
Table 31. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Application (2016-2021)
Table 33. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Application (2022-2027)
Table 34. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Application (2022-2027)
Table 35. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Application (2022-2027)
Table 37. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Application (2022-2027)
Table 38. North America Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Company (2016-2021)
Table 39. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2021) & (K Units)
Table 43. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2016-2021)
Table 44. North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2022-2027) & (K Units)
Table 45. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2022-2027)
Table 46. North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2021) & (K Units)
Table 47. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2016-2021)
Table 48. North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2022-2027) & (K Units)
Table 49. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2022-2027)
Table 50. Europe Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Company (2016-2021)
Table 51. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2021) & (K Units)
Table 55. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2016-2021)
Table 56. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2022-2027) & (K Units)
Table 57. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2022-2027)
Table 58. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2021) & (K Units)
Table 59. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2016-2021)
Table 60. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2022-2027) & (K Units)
Table 61. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2022-2027)
Table 62. China Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Company (2016-2021)
Table 63. China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2016-2021)
Table 64. China Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2021) & (K Units)
Table 67. China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2016-2021)
Table 68. China Herpes Simplex Virus (HSV) Vaccines Sales by Type (2022-2027) & (K Units)
Table 69. China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2022-2027)
Table 70. China Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2021) & (K Units)
Table 71. China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2016-2021)
Table 72. China Herpes Simplex Virus (HSV) Vaccines Sales by Application (2022-2027) & (K Units)
Table 73. China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2022-2027)
Table 74. Japan Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Company (2016-2021)
Table 75. Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2021) & (K Units)
Table 79. Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2016-2021)
Table 80. Japan Herpes Simplex Virus (HSV) Vaccines Sales by Type (2022-2027) & (K Units)
Table 81. Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2022-2027)
Table 82. Japan Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2021) & (K Units)
Table 83. Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2016-2021)
Table 84. Japan Herpes Simplex Virus (HSV) Vaccines Sales by Application (2022-2027) & (K Units)
Table 85. Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2022-2027)
Table 98. India Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Company (2016-2021)
Table 99. India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2016-2021)
Table 100. India Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2021) & (K Units)
Table 103. India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2016-2021)
Table 104. India Herpes Simplex Virus (HSV) Vaccines Sales by Type (2022-2027) & (K Units)
Table 105. India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2022-2027)
Table 106. India Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2021) & (K Units)
Table 107. India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2016-2021)
Table 108. India Herpes Simplex Virus (HSV) Vaccines Sales by Application (2022-2027) & (K Units)
Table 109. India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2022-2027)
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Sanofi Herpes Simplex Virus (HSV) Vaccines Product
Table 114. Sanofi Recent Development
Table 115. GlaxoSmithKline Corporation Information
Table 116. GlaxoSmithKline Description and Business Overview
Table 117. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product
Table 119. GlaxoSmithKline Recent Development
Table 120. Genocea Biosciences Corporation Information
Table 121. Genocea Biosciences Description and Business Overview
Table 122. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product
Table 124. Genocea Biosciences Recent Development
Table 125. Vical Corporation Information
Table 126. Vical Description and Business Overview
Table 127. Vical Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Vical Herpes Simplex Virus (HSV) Vaccines Product
Table 129. Vical Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Herpes Simplex Virus (HSV) Vaccines Distributors List
Table 133. Herpes Simplex Virus (HSV) Vaccines Customers List
Table 134. Herpes Simplex Virus (HSV) Vaccines Market Trends
Table 135. Herpes Simplex Virus (HSV) Vaccines Market Drivers
Table 136. Herpes Simplex Virus (HSV) Vaccines Market Challenges
Table 137. Herpes Simplex Virus (HSV) Vaccines Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Herpes Simplex Virus (HSV) Vaccines Product Picture
Figure 2. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2021 & 2027
Figure 6. HSV-1 (Oral Herpes) Examples
Figure 7. HSV-2 (Genital Herpes) Examples
Figure 8. Global Herpes Simplex Virus (HSV) Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Herpes Simplex Virus (HSV) Vaccines Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Herpes Simplex Virus (HSV) Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Herpes Simplex Virus (HSV) Vaccines Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Herpes Simplex Virus (HSV) Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Herpes Simplex Virus (HSV) Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Herpes Simplex Virus (HSV) Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Herpes Simplex Virus (HSV) Vaccines Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Herpes Simplex Virus (HSV) Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Herpes Simplex Virus (HSV) Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Herpes Simplex Virus (HSV) Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Herpes Simplex Virus (HSV) Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Herpes Simplex Virus (HSV) Vaccines Players Market Share by Revenue in Herpes Simplex Virus (HSV) Vaccines: 2016 & 2020
Figure 27. Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Type (2016-2021)
Figure 29. Global Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Application (2016-2021)
Figure 31. Global Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2020
Figure 33. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2020
Figure 34. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2020
Figure 35. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2020
Figure 36. China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2020
Figure 37. China Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2020
Figure 38. Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2020
Figure 39. Japan Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2020
Figure 40. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2020
Figure 41. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2020
Figure 42. India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2020
Figure 43. India Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Herpes Simplex Virus (HSV) Vaccines
Figure 46. Manufacturing Process Analysis of Herpes Simplex Virus (HSV) Vaccines
Figure 47. Herpes Simplex Virus (HSV) Vaccines Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed